LON:CIR Circassia Group (CIR) Share Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About Circassia Group Stock (LON:CIR) Get Circassia Group alerts:Sign Up Key Stats Today's Range N/A50-Day Range N/A52-Week Range N/AVolume4,513 shsAverage Volume773,465 shsMarket Capitalization£142.66 millionP/E Ratio3,400.00Dividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Circassia Group Plc, a medical device company, focuses on the respiratory diagnostics and monitoring products in the United States, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. It offers NIOX and NIOX VERO, a fractional exhaled nitric oxide measurement and monitoring products for use in asthma diagnosis and management. The company offers its products approximately in 50 countries through a network of distribution partners. The company was formerly known as Circassia Pharmaceuticals plc and changed its name to Circassia Group Plc in May 2020. Circassia Group Plc was incorporated in 2006 and is headquartered in Oxford, the United Kingdom. Read More Receive CIR Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Circassia Group and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. CIR Stock News HeadlinesParker Hannifin Buys Circor Aerospace Business for $2.5 BillionMay 21, 2026 | barrons.comParker-Hannifin Strikes $2.5 Billion Deal for Unit of KKR-Owned CircorMay 21, 2026 | wsj.comGoldman Sachs just told you what to buy (most people missed it)Goldman Sachs just revealed that 40% of AI data centers will be crippled by electricity shortages by 2027 - not chips, not funding, but power. Demand is growing 15% per year and the grid can't keep up. One small company makes the exact equipment these data centers need. They're sitting on $1.5 billion in orders, their hardware is already inside Musk's Colossus, and the stock still trades like a name nobody's heard of. Analyst Dylan Jovine is releasing the ticker for free.May 27 at 1:00 AM | Behind the Markets (Ad)Private equity firm withdraws takeover bid for NIOX GroupApril 11, 2025 | msn.comNiox Group PLC (NIOX)April 10, 2025 | uk.investing.comGlobal Respiratory Drugs Market to Register Incremental Growth at a CAGR of ~6% by 2030 | DelveInsightAugust 8, 2024 | finance.yahoo.comAllergy Shot Market Revenue Estimated to Grow at 6.1% CAGR to Reach US$ 3.34 Billion by 2034: Fact.MR ReportJuly 19, 2024 | finance.yahoo.comBTK Inhibitor Likely to Get a Pass to Phase III in Uncontrolled AsthmaMay 24, 2024 | msn.comSee More Headlines CIR Stock Analysis - Frequently Asked Questions How were Circassia Group's earnings last quarter? Circassia Group Plc (LON:CIR) released its quarterly earnings data on Thursday, September, 17th. The company reported ($3.00) earnings per share for the quarter. How do I buy shares of Circassia Group? Shares of CIR stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. What other stocks do shareholders of Circassia Group own? Based on aggregate information from My MarketBeat watchlists, some other companies that Circassia Group investors own include EnQuest (ENQ), Boohoo Group (BHOOY), Cummins (CMI), Tullow Oil (TLW), Ascential (ASCL), FutureFuel (FF) and H&T Group (HAT). Company Calendar Last Earnings9/17/2020Today5/27/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeLON SectorMedical Industry Biotechnology Sub-IndustryN/A Current SymbolLON:CIR CIKN/A Webwww.circassia.co.uk Phone44 1865 405 560FaxN/AEmployees111Year FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E Ratio3,400.00 Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity Ratio1.95 Current Ratio1.83 Quick Ratio1.50 Sales & Book Value Annual Sales£27.90 million Price / Sales0.00 Cash FlowN/A Price / Cash Flow11.33 Book ValueGBX 16 per share Price / BookN/AMiscellaneous Outstanding Shares419,578,000Free FloatN/AMarket Cap£142.66 million OptionableNot Optionable BetaN/A Don't wait for the SpaceX IPOThe space race is growing fast, and you don’t have to wait for SpaceX to go public to invest. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.Get This Free Report This page (LON:CIR) was last updated on 5/27/2026 by MarketBeat.com Staff. From Our PartnersThe 1934 playbookIn 1934, a legal government maneuver transferred billions in wealth overnight. Most Americans never saw it com...American Alternative | SponsoredSpaceX eyes a 1.75 trillion valuation - here's what to knowElon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...Brownstone Research | Sponsored$30 stock to buy before Starlink goes public (WATCH NOW!)In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...Paradigm Press | SponsoredTrump's gold order: the announcement they won't put on the front pageOn August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredYour book attachedBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredMy feud with Zohran MamdaniEmmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...Stansberry Research | SponsoredRead now. Do not delete. You’ve been warned.Three Nobel Prize Winners expose this once-in-a-generation wealth shift: “Don’t Say I Didn’t Warn You” P...Porter & Company | SponsoredSpaceX IPO hides a much bigger storyThe SpaceX IPO could be the biggest in history at $1.75 trillion - but the real story isn't the IPO itself. ...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Circassia Group Plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Circassia Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.